Crescent NV (BR:OPTI) — Stock Price
Crescent NV (BR:OPTI) is currently trading at €4.02 EUR, up 0.50% today. Over the past 52 weeks, shares have ranged between €0.00 and €10.38. This page tracks Crescent NV's live share price on the BR exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Crescent NV (OPTI) total market value.
Crescent NV (OPTI) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Crescent NV's daily closing share price and trading volume on the BR exchange over the past year, giving a clear view of recent price momentum and liquidity.
Crescent NV Income Statement — Revenue, Profit & Earnings by Year
Crescent NV's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | €9.23 Million | €12.55 Million | €11.41 Million | €15.65 Million | €16.23 Million |
| Cost of Revenue | €6.09 Million | €7.46 Million | €8.03 Million | €15.79 Million | €12.09 Million |
| Gross Profit | €3.14 Million | €5.09 Million | €3.38 Million | €5.32 Million | €4.14 Million |
| Research & Development | €611.00K | €1.43 Million | €1.61 Million | €1.16 Million | €387.00K |
| SG&A | — | €2.00 Million | €4.87 Million | €2.58 Million | €2.80 Million |
| Total Operating Expenses | €4.39 Million | €8.39 Million | €10.48 Million | €7.05 Million | €6.02 Million |
| Operating Income | €-1.25 Million | €-3.29 Million | €-7.09 Million | €-2.47 Million | €-1.88 Million |
| EBITDA | €-460.00K | €-1.84 Million | €-5.63 Million | €-539.00K | €-3.23 Million |
| EBIT | €-1.25 Million | €-3.40 Million | €-7.06 Million | €-2.53 Million | €-4.95 Million |
| Interest Expense | €562.00K | €818.00K | €654.00K | €544.00K | €588.00K |
| Income Before Tax | €-1.55 Million | €-4.11 Million | €-7.79 Million | €-3.07 Million | €-5.53 Million |
| Income Tax Expense | €-81.00K | €47.00K | €35.00K | €-503.00K | €37.00K |
| Net Income | €-2.25 Million | €-3.02 Million | €-7.01 Million | €-2.09 Million | €-5.63 Million |
Crescent NV Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Crescent NV's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | €10.04 Million | €14.33 Million | €22.62 Million | €28.88 Million | €19.65 Million |
| Total Current Assets | €3.31 Million | €4.91 Million | €10.82 Million | €7.53 Million | €4.13 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | €-115.00K | €-90.00K |
| Net Receivables | €1.91 Million | €3.19 Million | €1.64 Million | €4.93 Million | €2.50 Million |
| Inventory | €962.00K | €1.17 Million | €1.53 Million | €1.64 Million | €887.00K |
| Property, Plant & Equipment | — | — | — | €2.12 Million | €1.77 Million |
| Goodwill | €2.93 Million | €4.44 Million | €6.40 Million | €13.74 Million | €10.54 Million |
| Total Liabilities | €9.35 Million | €15.48 Million | €20.77 Million | €19.77 Million | €15.38 Million |
| Total Current Liabilities | €5.66 Million | €10.12 Million | €13.31 Million | €13.03 Million | €10.74 Million |
| Long-term Debt | — | €2.75 Million | €4.47 Million | €286.00K | €756.00K |
| Net Debt | €2.68 Million | €6.16 Million | €8.35 Million | €6.74 Million | €5.20 Million |
| Total Stockholder Equity | €681.00K | €-1.15 Million | €1.82 Million | €9.10 Million | €4.25 Million |
| Retained Earnings | €-2.33 Million | €-18.07 Million | €983.00K | €-7.82 Million | €-5.73 Million |
Crescent NV Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Crescent NV generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-937.00K | €-3.08 Million | €-638.00K | €-100.00K | €-66.00K |
| Capital Expenditures | €145.00K | €442.00K | €128.00K | €843.00K | €906.00K |
| Free Cash Flow | €-1.08 Million | €-3.53 Million | €-766.00K | €-943.00K | €-972.00K |
| Investing Cash Flow | €-253.00K | €5.85 Million | €-676.00K | €-1.02 Million | €-894.00K |
| Financing Cash Flow | €1.26 Million | €-2.94 Million | €1.07 Million | €1.30 Million | €698.00K |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | — | €0.00 | €8.00K | €22.00K | €535.00K |
| Depreciation | €791.00K | €1.56 Million | €1.43 Million | €1.99 Million | €1.71 Million |
| Change in Cash | €74.00K | €-180.00K | €-246.00K | €259.00K | €-262.00K |
Crescent NV Earnings History — EPS Actual vs. Analyst Estimates
Track Crescent NV's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 31, 2018 | -0.02 | — | — |
| Mar 04, 2010 | -660.12 | — | — |
| Oct 29, 2009 | -147.57 | — | — |
| Jul 30, 2009 | -191.44 | — | — |
| Apr 30, 2009 | -85.21 | — | — |
| Mar 05, 2009 | -215.21 | — | — |
| Oct 30, 2008 | -47.18 | — | — |
| Jul 24, 2008 | -92.96 | — | — |